{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibss7xx5krc4voradckyi3v62rd5rxgrb3q46p5lrlg3s7x3pzfdq",
    "uri": "at://did:plc:4zlmjfmdbxj3qhzh3qrwdw6u/app.bsky.feed.post/3memnntnxrgf2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicpa2bxmshm5wnycamk7l77bhgddrilgdebmyvkuxlka5iyy2sccm"
    },
    "mimeType": "image/png",
    "size": 34920
  },
  "path": "/newsletter/the-daily/what-ozempic-reveals-about-the-human-brain",
  "publishedAt": "2026-02-11T23:30:00.000Z",
  "site": "https://www.newyorker.com",
  "tags": [
    "Newsletter / The Daily",
    "Disable Inline Signup Unit"
  ],
  "textContent": "From the daily newsletter: GLP-1s have earned a reputation as “moderation molecules.”",
  "title": "What Ozempic Reveals About the Human Brain"
}